Lung cancer following therapy for Hodgkin's disease

We describe a patient in whom lung cancer developed several years after he had received combined-modality therapy for Hodgkin''s disease. The literature concerning second malignant diseases, particularly thoracic tumours, that occur following combined-modality therapy for cancer is reviewed. It is important to recognize these entities, because chest symptoms or findings on x-ray films may be misinterpreted as representing late recrudescence of the first neo-plastic disease.